PubRank

Dose-Escalated Irradiation and Overall Survival in Men With Nonmetastatic Prostate Cancer.

PubWeight™: 2.16‹?› | Rank: Top 2%

🔗 View Article (PMID 26181727)

Published in JAMA Oncol on October 01, 2015

Authors

Anusha Kalbasi1, Jiaqi Li2, Abigail Berman1, Samuel Swisher-McClure3, Marc Smaldone4, Robert G Uzzo4, Dylan S Small5, Nandita Mitra6, Justin E Bekelman7

Author Affiliations

1: Department of Radiation Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
2: Department of Biostatistics and Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia3Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
3: Department of Radiation Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia4Leonard Davis Institute of Health, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
4: Division of Urologic Oncology, Department of Surgery, Fox Chase Cancer Center, Temple University Health System, Philadelphia, Pennsylvania.
5: Leonard Davis Institute of Health, Perelman School of Medicine at the University of Pennsylvania, Philadelphia6Department of Statistics, The Wharton School at the University of Pennsylvania, Philadelphia.
6: Department of Biostatistics and Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
7: Department of Radiation Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia7Department of Medical Ethics and Health Policy, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.

Articles citing this ↘

Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer. J Clin Oncol (2016) 1.17

Prostate Radiotherapy in the Era of Advanced Imaging and Precision Medicine. Prostate Cancer (2016) 0.78

Dosimetric impact in the dose-volume histograms of rectal and vesical wall contouring in prostate cancer IMRT treatments. Rep Pract Oncol Radiother (2017) 0.78

Dose-Escalated Radiotherapy for Prostate Cancer: Is the Sky the Limit? JAMA Oncol (2015) 0.75

Significant impact of biochemical recurrence on overall mortality in patients with high-risk prostate cancer after carbon-ion radiotherapy combined with androgen deprivation therapy. Cancer (2016) 0.75

Racial Disparity in Prostate Cancer-Specific Mortality for High-Risk Prostate Cancer: A Population-Based Study. Cureus (2017) 0.75

Prostate Cancer Radiation Therapy: What Do Clinicians Have to Know? Biomed Res Int (2016) 0.75

Re: Dose-Escalated Irradiation and Overall Survival in Men with Nonmetastatic Prostate Cancer. J Urol (2015) 0.75

Ten-year outcomes of intensity-modulated radiation therapy combined with neoadjuvant hormonal therapy for intermediate- and high-risk patients with T1c-T2N0M0 prostate cancer. Int J Clin Oncol (2016) 0.75